Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hales RK"" wg kryterium: Autor


Wyświetlanie 1-6 z 6
Tytuł:
An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis.
Autorzy:
Liang KL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.
Tackett S; Division of General Internal Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD 21224, USA.; Biostatistics, Epidemiology and Data Management Core, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.
Myers S; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.
Brahmer JR; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD 21287, USA.
Browner IS; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.
Ettinger DS; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.
Forde PM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD 21287, USA.
Hales RK; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.
Hann CL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD 21287, USA.
Lam VK; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD 21287, USA.
Marrone KA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD 21287, USA.
Patel T; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.
Peterson V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.
Sagorsky S; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.
Turner M; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.
Voong KR; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.
Naidoo J; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD 21287, USA.; Department of Oncology, Beaumont Hospital Dublin, RCSI University of Health Sciences, D02 YN77 Dublin, Ireland.
Feliciano JL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD 21287, USA.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Jun 17; Vol. 29 (6), pp. 4342-4353. Date of Electronic Publication: 2022 Jun 17.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents, Immunological*/therapeutic use
Drug-Related Side Effects and Adverse Reactions*/drug therapy
Neoplasms*/drug therapy
Neoplasms*/pathology
Ambulatory Care Facilities ; Humans ; Medical Oncology ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Bone density and fracture risk following SBRT for non-spine bone metastases.
Autorzy:
Cao Y; Johns Hopkins University School of Medicine, Department of Radiation Oncology and Molecular Radiation Sciences, Baltimore, MD, USA.
Stachelek GC; Johns Hopkins University School of Medicine, Department of Radiation Oncology and Molecular Radiation Sciences, Baltimore, MD, USA.
Fu W; Johns Hopkins University School of Medicine, Department of Statistics and Bioinformatics, Baltimore, MD, USA.
Song DY; Johns Hopkins University School of Medicine, Department of Radiation Oncology and Molecular Radiation Sciences, Baltimore, MD, USA.
Hales RK; Johns Hopkins University School of Medicine, Department of Radiation Oncology and Molecular Radiation Sciences, Baltimore, MD, USA.
Voong KR; Johns Hopkins University School of Medicine, Department of Radiation Oncology and Molecular Radiation Sciences, Baltimore, MD, USA.
Meyer JJ; Johns Hopkins University School of Medicine, Department of Radiation Oncology and Molecular Radiation Sciences, Baltimore, MD, USA.
Quon H; Johns Hopkins University School of Medicine, Department of Radiation Oncology and Molecular Radiation Sciences, Baltimore, MD, USA.
Hu C; Johns Hopkins University School of Medicine, Department of Statistics and Bioinformatics, Baltimore, MD, USA.
Redmond KJ; Johns Hopkins University School of Medicine, Department of Radiation Oncology and Molecular Radiation Sciences, Baltimore, MD, USA.
Pokaż więcej
Źródło:
Journal of radiosurgery and SBRT [J Radiosurg SBRT] 2021; Vol. 7 (3), pp. 199-206.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Radiologic response of chemotherapy alone versus radiation and chemotherapy in the treatment of locally-advanced or advanced thymic epithelial tumors.
Autorzy:
Chu RF; The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Hussien A; Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland, USA.
Li QK; Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
Wang J; Department of Biostatistics, Johns Hopkins University, Baltimore, Maryland, USA.
Friedes C; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
Ferro A; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
Hales RK; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
Battafarano R; Department of Surgery, Division of Thoracic Surgery, Johns Hopkins University, Baltimore, Maryland, USA.
Ettinger DS; Department of Oncology, Johns Hopkins University, Baltimore, Maryland, USA.
Voong KR; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2020 Oct; Vol. 11 (10), pp. 2924-2931. Date of Electronic Publication: 2020 Sep 01.
Typ publikacji:
Journal Article
MeSH Terms:
Chemoradiotherapy/*methods
Neoplasms, Glandular and Epithelial/*radiotherapy
Thymus Neoplasms/*radiotherapy
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Neoplasms, Glandular and Epithelial/pathology ; Thymus Neoplasms/pathology
SCR Disease Name:
Thymic epithelial tumor
Czasopismo naukowe
Tytuł:
Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impact.
Autorzy:
Hazell SZ; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, 300 Mason Lord Drive, Baltimore, MD, 21224, USA.
Mai N; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, 300 Mason Lord Drive, Baltimore, MD, 21224, USA.
Fu W; Department of Oncology, Biostatistics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Hu C; Department of Oncology, Biostatistics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Friedes C; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, 300 Mason Lord Drive, Baltimore, MD, 21224, USA.
Negron A; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, 300 Mason Lord Drive, Baltimore, MD, 21224, USA.
Voong KR; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, 300 Mason Lord Drive, Baltimore, MD, 21224, USA.
Feliciano JL; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Han P; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, 300 Mason Lord Drive, Baltimore, MD, 21224, USA.
Myers S; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
McNutt TR; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, 300 Mason Lord Drive, Baltimore, MD, 21224, USA.
Hales RK; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, 300 Mason Lord Drive, Baltimore, MD, 21224, USA. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2020 Apr 19; Vol. 20 (1), pp. 334. Date of Electronic Publication: 2020 Apr 19.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung/*mortality
Carcinoma, Small Cell/*mortality
Carcinoma, Squamous Cell/*mortality
Hospitalization/*statistics & numerical data
Lung Neoplasms/*mortality
Radiotherapy/*mortality
Risk Assessment/*methods
Adenocarcinoma of Lung/epidemiology ; Adenocarcinoma of Lung/pathology ; Adenocarcinoma of Lung/radiotherapy ; Adult ; Aged ; Aged, 80 and over ; Carcinoma, Small Cell/epidemiology ; Carcinoma, Small Cell/pathology ; Carcinoma, Small Cell/radiotherapy ; Carcinoma, Squamous Cell/epidemiology ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/radiotherapy ; Female ; Follow-Up Studies ; Humans ; Incidence ; Lung Neoplasms/epidemiology ; Lung Neoplasms/pathology ; Lung Neoplasms/radiotherapy ; Male ; Middle Aged ; Prognosis ; Quality of Life ; Radiotherapy/adverse effects ; Retrospective Studies ; Risk Factors ; Survival Rate ; United States/epidemiology
Czasopismo naukowe
Tytuł:
Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.
Autorzy:
Alcorn S; Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Walker AJ
Gandhi N
Narang A
Wild AT
Hales RK
Herman JM
Song DY
Deweese TL
Antonarakis ES
Tran PT
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2013 Jul 16; Vol. 14 (7), pp. 14800-32. Date of Electronic Publication: 2013 Jul 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
MeSH Terms:
Prostatic Neoplasms/*radiotherapy
Radiation-Sensitizing Agents/*therapeutic use
Animals ; Biomarkers/metabolism ; Clinical Trials as Topic ; Drug Evaluation, Preclinical ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/metabolism ; HSP90 Heat-Shock Proteins/antagonists & inhibitors ; HSP90 Heat-Shock Proteins/metabolism ; Humans ; Male ; TOR Serine-Threonine Kinases/antagonists & inhibitors ; TOR Serine-Threonine Kinases/metabolism ; src-Family Kinases/antagonists & inhibitors ; src-Family Kinases/metabolism
Czasopismo naukowe
Tytuł:
Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma.
Autorzy:
Wild AT; Department of Radiation Oncology & Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Gandhi N
Chettiar ST
Aziz K
Gajula RP
Williams RD
Kumar R
Taparra K
Zeng J
Cades JA
Velarde E
Menon S
Geschwind JF
Cosgrove D
Pawlik TM
Maitra A
Wong J
Hales RK
Torbenson MS
Herman JM
Tran PT
Pokaż więcej
Źródło:
PloS one [PLoS One] 2013 Jun 06; Vol. 8 (6), pp. e65726. Date of Electronic Publication: 2013 Jun 06 (Print Publication: 2013).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*therapeutic use
Carcinoma, Hepatocellular/*therapy
Combined Modality Therapy/*methods
Gamma Rays/*therapeutic use
Histones/*genetics
Liver Neoplasms/*therapy
Niacinamide/*analogs & derivatives
Phenylurea Compounds/*therapeutic use
Animals ; Apoptosis/drug effects ; Apoptosis/radiation effects ; Carcinoma, Hepatocellular/blood supply ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/pathology ; Cell Cycle/drug effects ; Cell Cycle/radiation effects ; Cell Line, Tumor ; Clinical Trials as Topic ; DNA Breaks, Double-Stranded/drug effects ; DNA Breaks, Double-Stranded/radiation effects ; Gene Expression/drug effects ; Gene Expression/radiation effects ; Hindlimb/blood supply ; Hindlimb/metabolism ; Hindlimb/pathology ; Histones/metabolism ; Humans ; Liver Neoplasms/blood supply ; Liver Neoplasms/genetics ; Liver Neoplasms/pathology ; Mice ; Mice, Nude ; Neovascularization, Pathologic/prevention & control ; Niacinamide/therapeutic use ; Radiation Tolerance ; Sorafenib ; Tumor Burden/drug effects ; Xenograft Model Antitumor Assays
Czasopismo naukowe
    Wyświetlanie 1-6 z 6

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies